This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations of Xinyue Liu-Chen in Cancer Research
Introduction
Xinyue Liu-Chen is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research through his innovative work on thymidylate synthase. His research focuses on the mutations of this enzyme, which play a crucial role in cancer treatment.
Latest Patents
Xinyue Liu-Chen holds a patent titled "Mutants of thymidylate synthase and uses thereof." This invention provides a mutated human thymidylate synthase that differs from the wild type at specific amino acid residues, including 49, 52, 108, 221, and 225. The patent also includes cDNA for mutated human TSs, novel vectors, host cells, and methods for utilizing these mutated enzymes in therapeutic applications. He has 1 patent to his name.
Career Highlights
Xinyue Liu-Chen is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research. His work is pivotal in understanding the mechanisms of cancer and developing targeted therapies.
Collaborations
He collaborates with esteemed colleagues, including Youzhi Tong and Joseph R. Bertino, to advance research in cancer treatment and enzyme functionality.
Conclusion
Xinyue Liu-Chen's innovative contributions to cancer research through his patented work on thymidylate synthase highlight the importance of scientific advancements in the fight against cancer. His ongoing research continues to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile